REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanofi Russia ZAO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical and Medicine Manufacturing
Full name: Sanofi Russia ZAO Profile Updated: June 27, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Russian Download a sample report

JSC "Sanofi Russia" is the Russian subsidiary of a major French pharmaceutical company "Sanofi-Sintelabo SA". The joint stock company "Sanofi Russia" is engaged in the production and wholesale trade of pharmaceutical and medical goods.

Headquarters
Ulitsa Tverskaya, Dom 22
Moscow; Moscow; Postal Code: 125009

Contact Details: Purchase the Sanofi Russia ZAO report to view the information.

Website: http://sanofi.ru

Basic Information
Total Employees:
Purchase the Sanofi Russia ZAO report to view the information.
Registered Capital:
Purchase the Sanofi Russia ZAO report to view the information.
Incorporation Date:
June 13, 2000
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Nekommercheskaya Organizaciya Soyuz Professionalinyh Farmacevticheskih Organizacii
Company Performance
Financial values in the chart are available after Sanofi Russia ZAO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
8.81%
Total operating revenue
8.81%
Operating profit (EBIT)
-11.87%
Net Profit (Loss) for the Period
-56.52%
Total assets
-9.89%
Total equity
-3.82%
Operating Profit Margin (ROS)
-2.76%
Net Profit Margin
-2.75%
Return on Equity (ROE)
-4.39%
Debt to Equity Ratio
-6.74%
Quick Ratio
1%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?